Pharma’s Almanac December, 14, 2024 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 The omnipresent dynamic of 2023 has been the decline in COVID, with patients, providers, and the pharma/biopharma industry adjusting to the aftermath of the pandemic. COVID-related deaths continue to fall, currently reaching levels seen in the very early days of[…]
Dermatology Times December 15, 2023 Stefan Weiss, MD, MBA, FAAD Read the full article >> 2023 brought exciting advances in the treatment of alopecia areata and vitiligo, autoimmune skin conditions that can significantly impact a person’s physical appearance and emotional well-being. The emergence of Janus kinase (JAK) inhibitors has shown tremendous promise as a novel[…]
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
HealthEconomics.com November 15, 2023 Listen to the full podcast >> The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine[…]
Healthcare Innovation September 19, 2023 Read the full article >> Congratulations to 40 Under 40 Winner: Joseph Zabinski, PhD, MEM, Managing Director of AI & Personalized Medicine, OM1 Get To Know Joseph: Age (as of December 31, 2023): 35 Hometown: Cortlandt Manor, NY Alma Mater: Boston College (BS), Dartmouth (MEM), UNC (PhD) Number of Years of Experience in Healthcare: 8[…]
